Epstein Secrets

- Russia - remains the more potent adversary, and has in recent months EFTA00135800 stolen data from at least two county systems in California and Indiana, according to U.S. officials." Newsweek (10/22, Lemon, 1.53M) reports that Democratic Lawmakers "have criticized President Donald Trump's administr

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

different foe — Russia — remains the more potent adversary, and has in recent months stolen data from at least two county systems in California and Indiana, according to U.S. officials." Newsweek <https://www.newsweek.com/democrats-criticize-trump-administration-over-false-equivalences- between-iranian-

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

different foe - Russia - remains the more potent adversary, and has in recent months stolen data from at least two county systems in California and Indiana, according to U.S. officials." Newsweek (10/22, Lemon, 1.53M) reports that Democratic Lawmakers "have criticized President Donald Trump's administr

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug